financetom
Business
financetom
/
Business
/
MicroStrategy Launches Customizable AI Bot
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MicroStrategy Launches Customizable AI Bot
Mar 26, 2024 11:43 AM

02:21 PM EDT, 03/26/2024 (MT Newswires) -- MicroStrategy ( MSTR ) said Tuesday it has launched its customizable artificial intelligence bot, MicroStrategy Auto, that offers a faster, simpler way to deliver business intelligence to an organization.

Auto can be deployed as a stand-alone app in the MicroStrategy ONE library or embedded into third-party applications, it said.

The shares were up about 1.6% in recent trading.

Price: 1886.07, Change: +30.07, Percent Change: +1.62

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United Therapeutics Insider Sold Shares Worth $5,112,335, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $5,112,335, According to a Recent SEC Filing
Nov 13, 2025
04:38 PM EST, 11/13/2025 (MT Newswires) -- Paul A Mahon, Executive Vice President & General Counsel, on November 13, 2025, sold 11,000 shares in United Therapeutics ( UTHR ) for $5,112,335. Following the Form 4 filing with the SEC, Mahon has control over a total of 36,781 common shares of the company, with 36,781 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000123158925000010/xslF345X05/primarydocument.xml...
EV charging firm Nuvve's Q3 revenue falls 
EV charging firm Nuvve's Q3 revenue falls 
Nov 13, 2025
Overview * Nuvve Q3 2025 revenue fell 16.7% yr/yr to $1.6 mln * Net loss for Q3 2025 increased to $4.8 mln from $1.6 mln yr/yr * Company raised $5.6 mln through public offering and debt in Q3 2025 Outlook * Nuvve ( NVVE ) anticipates expanding its stationary battery business in North America, Europe, and Japan * Company focuses...
Huntington Ingalls Industries Insider Sold Shares Worth $4,815,900, According to a Recent SEC Filing
Huntington Ingalls Industries Insider Sold Shares Worth $4,815,900, According to a Recent SEC Filing
Nov 13, 2025
04:38 PM EST, 11/13/2025 (MT Newswires) -- Christopher D Kastner, Director, President & CEO, on November 12, 2025, sold 15,000 shares in Huntington Ingalls Industries ( HII ) for $4,815,900. Following the Form 4 filing with the SEC, Kastner has control over a total of 70,503 common shares of the company, with 2,264 shares held directly and 68,239 controlled indirectly....
Biopharmaceutical firm VistaGen's fiscal Q2 net loss widens
Biopharmaceutical firm VistaGen's fiscal Q2 net loss widens
Nov 13, 2025
Overview * VistaGen fiscal Q2 net loss widens to $19.4 mln from $13.0 mln year-over-year * R&D expenses increased to $15.9 mln, driven by PALISADE Program costs * Company expects PALISADE-3 Phase 3 trial results by year-end Outlook * VistaGen expects PALISADE-3 trial results by year-end 2025 * PALISADE-4 trial results anticipated in H1 2026 Result Drivers * R&D EXPENSES...
Copyright 2023-2026 - www.financetom.com All Rights Reserved